Pliant Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLRX research report →
About the company
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avß6 and avß1 integrins, which is currently progressing through three distinct Phase 2a clinical trials.
- CEO
- Bernard Coulie
- IPO
- 2020
- Employees
- 171
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $72.45M
- P/E
- -0.64
- P/S
- 0.00
- P/B
- 0.44
- EV/EBITDA
- -0.73
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -59.06%
- ROIC
- -61.46%
- Revenue
- $0 · 0.00%
- Net Income
- $-149,344,000 · 28.99%
- EPS
- $-2.43 · 29.97%
- Op Income
- $-150,073,000
- FCF YoY
- 19.23%
- 52W High
- $1.95
- 52W Low
- $1.09
- 50D MA
- $1.19
- 200D MA
- $1.34
- Beta
- 1.21
- Avg Volume
- 468.15K
Get TickerSpark's AI analysis on PLRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | CROWELL GAYLE A | other | 70,000 |
| Jun 11, 26 | MCCOURT Thomas A | other | 70,000 |
| Jun 11, 26 | Krognes Steve E. | other | 70,000 |
| Jun 11, 26 | Curnutte John T | other | 70,000 |
| Jun 11, 26 | Huh Hoyoung | other | 70,000 |
| Jun 11, 26 | Cline Darren S | other | 70,000 |
| Apr 17, 26 | Kuo Minnie | other | 150,000 |
| Apr 17, 26 | Kuo Minnie | other | 55,200 |
| Apr 17, 26 | Kuo Minnie | other | 40,000 |
| Apr 17, 26 | Kuo Minnie | sell | 150,000 |
Our PLRX coverage
Recent articles, reports, and earnings notes.
No research on PLRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PLRX report →Similar companies
Peers in the same neighborhood.